Skip to content

Research on chronic pain treatment with MSC-CM

Research on chronic pain treatment with human-derived mesenchymal stem cell conditioned medium

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1051260047
Enrollment
100
Registered
2026-05-13
Start date
2026-03-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic pain Arthritis pain, Back pain, Persistent pain, Neuropathic pain, Musculoskeletal pain

Interventions

None listed

Sponsors

Tachibana Jun
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Individuals who did not experience satisfactory pain relief effects with standard therapy. 2. Individuals who do not wish to undergo treatment with drugs commonly used in standard therapy due to concerns about side effects, and whose physicians have determined that treatment with conditioned medium is appropriate for chronic pain relief. Patients meeting the following criteria are eligible: 1. Individuals aged 18 years or older. 2. Individuals with normal capacity to consent. 3. Individuals who have been provided with the informed consent document for this treatment, have received sufficient explanation, and are capable of providing written consent freely and voluntarily. 4. Individuals for whom the attending physician has recognized the necessity of treatment.

Exclusion criteria

Exclusion criteria: Individuals meeting any of the following conditions will be excluded: 1. Users of narcotics or stimulants. 2. Individuals deemed inappropriate by the attending physician.

Design outcomes

Primary

MeasureTime frame
The self-reported symptoms of pain in the research subjects are as follows: 1) Impact of pain on daily life 2) Pattern of pain 3) Intensity of pain (Numerical Rating Scale; NRS) 4) Location of pain 5) Characteristic of pain

Contacts

Public ContactJun Tachibana

Stem Cell Clinic Tokyo

kansaibou.clinic.tokyo@gmail.com+81-362806020

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026